Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - DoubtfulReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Exponent (EXPO) over the last 16 years, with Q4 2025 value amounting to $12.9 million.

  • Exponent's Current Deferred Revenue fell 381.69% to $12.9 million in Q4 2025 from the same period last year, while for Oct 2025 it was $12.9 million, marking a year-over-year decrease of 381.69%. This contributed to the annual value of $16.4 million for FY2025, which is 2459.81% down from last year.
  • According to the latest figures from Q4 2025, Exponent's Current Deferred Revenue is $12.9 million, which was down 381.69% from $11.7 million recorded in Q3 2025.
  • Exponent's 5-year Current Deferred Revenue high stood at $21.7 million for Q4 2023, and its period low was $8.9 million during Q2 2021.
  • Over the past 5 years, Exponent's median Current Deferred Revenue value was $13.8 million (recorded in 2024), while the average stood at $14.3 million.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first soared by 7593.76% in 2022, then plummeted by 3357.61% in 2023.
  • Exponent's Current Deferred Revenue (Quarter) stood at $19.8 million in 2021, then fell by 4.7% to $18.8 million in 2022, then grew by 15.26% to $21.7 million in 2023, then crashed by 38.21% to $13.4 million in 2024, then decreased by 3.82% to $12.9 million in 2025.
  • Its Current Deferred Revenue was $12.9 million in Q4 2025, compared to $11.7 million in Q3 2025 and $13.8 million in Q2 2025.